Abstract:B141 Lipoxygenase inhibitors have been reported to inhibit cell growth and/or induce apoptosis in various tumors including hepatic, colorectal, mammary, lung, and gliomas. We tested the effect of wogonin (5,7-dihydroxy-8-methoxyflavone), a lipoxygenase inhibitor, in ER-positive (MCF-7 and T47D) and -negative breast cancer cell lines (MDA-MB-231 and SK-BR-3). Anchorage-dependent cell growth was attenuated by wogonin, independently of its ER status, in a dose- and time-dependent manner. Flow cytometry analysis gave enhanced sub-G1 population by wogonin, which is indicative of augmented apoptosis. Moreover, enhanced nuclear fragmentation was observed by DAPI staining. Furthermore, anti-apoptotic Bcl-2 and Bcl-xL proteins were reduced, while pro-apoptotic Bax was enhanced in wogonin-treated cells. Total and phosphorylated forms of Akt were downregulated by wogonin. Total and phosphorylated forms of GSK-3β were reduced, as well as Cyclin D1 protein, which implies the downregulation of the canonical Wnt signaling pathway by wogonin. In ER-positive MCF-7 and T47D cells, the expression of ER was down-regulated by wogonin, which might have additionally contributed to attenuated cell proliferation. Likewise, the expression of EGFR and c-ErbB2 and their phosphorylated forms were down-regulated by wogonin in ER-negative MDA-MB-231 and SK-BR-3 cells, respectively. Finally, the growth of T47D, MDA-MB-231, and SK-BR-3 xenografts was attenuated by oral administration of wogonin for 4 weeks. As we have shown the inhibitory effect of wogonin both in vitro and in vivo, our novel findings open the possibility of wogonin as an effective therapeutic agent against both ER-positive and -negative breast cancers, particularly against the more aggressive and hormonal therapy-resistant ER-negative, EGFR or c-ErbB2-overexpressing types.

Effects of Wogonin on Proliferation and Cell Cycle of SPC-A-1 Cells

Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721.

Effects of Wogonin on the Apoptosis of Human Glioma Cell Line U251

Effect of Magnetic Nanoparticles on Apoptosis and Cell Cycle Induced by Wogonin in Raji Cells

Inhibitory Effect of Platycodin D on Human Colonic Cancer SW620 Cell Proliferation

The anti-timour effect of ethanol extract of Rhizoma Atractylodis on SKOV-3 cells

Effects of wogonin on the growth and metastasis of colon cancer through the Hippo signaling pathway

Effects of wogonin on the mechanism of melanin synthesis in A375 cells

The Antitumor effect of wogonin, a lipoxygenase inhibitor, in both estrogen receptor-positive and -negative human breast cancers.

Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells

Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis

Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells

Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation

Wogonin Inhibits Nasopharyngeal Carcinoma Cells

Effects of Coicis Semen oil on growth of human in situ pancreatic cancer cell line BxPC-3 and expression of VEGF and bFGF

On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation

Wogonin Inhibits Colorectal Cancer Proliferation and Epithelial Mesenchymal Transformation by Suppressing Phosphorylation in the AKT Pathway

Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins

Wogonin Increases Doxorubicin Sensitivity by Down-Regulation of IGF-1R/AKT Signaling Pathway in Human Breast Cancer.

Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling

Synergistic Inhibitory Effect of Wogonin and Low-Dose Paclitaxel on Gastric Cancer Cells and Tumor Xenografts